Phase I study of BMS-690514 in Japanese patients with solid tumors
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2008
At a glance
- Drugs BMS 690514 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 29 Sep 2008 Planned end date changed from 1 Dec 2008 to 1 Jul 2008 as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2008 Planned number of patients changed from 30 to 9 as reported by ClinicalTrials.gov.